McNicoll Lewis & Vlak Upgrades AMAG Pharmaceuticals (AMAG) to Buy; Highly Encouraged
Tweet Send to a Friend
McNicoll Lewis & Vlak upgraded AMAG Pharmaceuticals (NASDAQ: AMAG) from Hold to Buy. PT $25.
MLV analyst says, "We see ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
MLV analyst says, "We see ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
